Eisai
4523.T
#1920
Rank
โ‚น712.35 B
Marketcap
โ‚น2,527
Share price
-0.56%
Change (1 day)
-41.10%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): โ‚น36.20 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น44.26 Billion, an increase over its 2022 earnings that were of -โ‚น1.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น36.20 B-18.21%
2023 โ‚น44.26 B-2392.87%
2022 -โ‚น1.94 Billion-103.6%
2021 โ‚น53.64 B-39.52%
2020 โ‚น88.69 B7.3%
2019 โ‚น82.65 B17.23%
2018 โ‚น70.51 B86.06%
2017 โ‚น37.89 B-23.64%
2016 โ‚น49.63 B27.28%
2015 โ‚น38.99 B22.08%
2014 โ‚น31.94 B-46.11%
2013 โ‚น59.27 B-21.67%
2012 โ‚น75.67 B-20.72%
2011 โ‚น95.45 B-8.44%
2010 โ‚น104.25 B18.85%
2009 โ‚น87.71 B